EWALL-PH OBSERVARTORY 2022

Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma

NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2

Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL

NCT07493161 ·Status: RECRUITING ·Phase: NA

A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients

NCT07644351 ·Status: COMPLETED

Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy

NCT07609485 ·Status: RECRUITING

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

NCT04984356 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438 ·Status: COMPLETED ·Phase: PHASE2

Determining the Mechanisms of Loss of CAR T Cell Persistence

NCT05809284 ·Status: RECRUITING

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT06508658 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

NCT05776134 ·Status: AVAILABLE

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

NCT06481241 ·Status: RECRUITING ·Phase: NA

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

NCT07001384 ·Status: RECRUITING ·Phase: PHASE1

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

NCT05043571 ·Status: RECRUITING ·Phase: PHASE1

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

NCT03512405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia

NCT00511069 ·Status: COMPLETED ·Phase: PHASE2

A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL

NCT04860817 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma

NCT04296461 ·Status: UNKNOWN ·Phase: PHASE1

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

NCT03194893 ·Status: COMPLETED ·Phase: PHASE3

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

NCT04149821 ·Status: TERMINATED ·Phase: PHASE2

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

NCT06034561 ·Status: RECRUITING ·Phase: PHASE2

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518 ·Status: RECRUITING ·Phase: PHASE1

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

NCT03571321 ·Status: RECRUITING ·Phase: PHASE1

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952 ·Status: COMPLETED ·Phase: PHASE1

Axicabtagene Ciloleucel Expanded Access Study

NCT03153462 ·Status: APPROVED_FOR_MARKETING

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

NCT07518329 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1